The adipocyte differentiation protein APMAP is an endogenous suppressor of A? production in the brain.
Ontology highlight
ABSTRACT: The deposition of amyloid-beta (A?) aggregates in the brain is a major pathological hallmark of Alzheimer's disease (AD). A? is generated from the cleavage of C-terminal fragments of the amyloid precursor protein (APP-CTFs) by ?-secretase, an intramembrane-cleaving protease with multiple substrates, including the Notch receptors. Endogenous modulation of ?-secretase is pointed to be implicated in the sporadic, age-dependent form of AD. Moreover, specifically modulating A? production has become a priority for the safe treatment of AD because the inhibition of ?-secretase results in adverse effects that are related to impaired Notch cleavage. Here, we report the identification of the adipocyte differentiation protein APMAP as a novel endogenous suppressor of A? generation. We found that APMAP interacts physically with ?-secretase and its substrate APP. In cells, the partial depletion of APMAP drastically increased the levels of APP-CTFs, as well as uniquely affecting their stability, with the consequence being increased secretion of A?. In wild-type and APP/ presenilin 1 transgenic mice, partial adeno-associated virus-mediated APMAP knockdown in the hippocampus increased A? production by ?20 and ?55%, respectively. Together, our data demonstrate that APMAP is a negative regulator of A? production through its interaction with APP and ?-secretase. All observed APMAP phenotypes can be explained by an impaired degradation of APP-CTFs, likely caused by an altered substrate transport capacity to the lysosomal/autophagic system.
SUBMITTER: Mosser S
PROVIDER: S-EPMC4275069 | biostudies-literature | 2015 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA